☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
identification
Acceleron Signs a License Agreement with Fulcrum for the Identification of Therapies to Treat Pulmonary Diseases
December 31, 2019
Roche Reports Launch of First CDx VENTANA PD-L1 (SP142) Assay Identifying TNBC Patients Eligible for Treatment with Tecentriq (ate...
August 29, 2019
Roche Launches Ventana HER2 Dual ISH CDx for the Identification of Breast and Gastric Cancer
April 23, 2019
Load more...
Back to Home
Modal title
×
Modal body text goes here.